Skip to main content
Clinical Trials/JPRN-UMIN000020732
JPRN-UMIN000020732
Completed
Phase 1

An exploratory clinical trial for the congenital melanocytic nevi using the noble combination therapy with the inactivated autologous nevus tissue by high hydrostatic pressure and the cultured epithelial autograft - The noble combination therapy with the inactivated nevus tissue by high hydrostatic pressure and the cultured epithelial autograft

Department of Plastic and Reconstructive Surgery, Kansai Medical University0 sites10 target enrollmentJanuary 26, 2016

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Melanocytic nevi
Sponsor
Department of Plastic and Reconstructive Surgery, Kansai Medical University
Enrollment
10
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 26, 2016
End Date
August 30, 2018
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Plastic and Reconstructive Surgery, Kansai Medical University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Patients with scar tissue that prevent the take of inactivated nevus 2\.The nevus that has been treated by cultured epidermal autografts already. 3\.A history of malignant tumor with disease free interval of 5 years or less 4\.Other patients judged by the investigator or sub\-investigator to be inappropriate as a subject of this study. 5\.Patients who have received this protocol treatments twice.

Outcomes

Primary Outcomes

Not specified

Similar Trials